AstraZeneca has canceled its plan to invest £450 million in expanding its vaccine manufacturing facility in Merseyside, attributing this decision to reduced government support. This announcement comes shortly after the Labour government outlined its economic growth strategy. AstraZeneca stated that ongoing discussions revealed discrepancies between the government's financial proposals. Despite halting the expansion, the company affirmed that current jobs at the Speke facility would not be impacted and that it would continue to manufacture flu vaccines for domestic and international markets.
AstraZeneca has scrapped plans to invest £450 million in a vaccine manufacturing plant in Merseyside, citing reduced government support as a key factor.
Despite the scrapped expansion, AstraZeneca confirmed that the Merseyside site will continue to produce and supply flu vaccines for both the UK and global markets.
Collection
[
|
...
]